{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T02:33:05Z","timestamp":1784860385753,"version":"3.55.0"},"reference-count":28,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Ther Med"],"DOI":"10.3892\/etm.2019.7397","type":"journal-article","created":{"date-parts":[[2019,3,14]],"date-time":"2019-03-14T07:09:54Z","timestamp":1552547394000},"source":"Crossref","is-referenced-by-count":11,"title":["DL\u20113\u2011n\u2011butylphthalide therapy for Parkinson's disease: A randomized controlled trial"],"prefix":"10.3892","author":[{"given":"Haiyan","family":"Zhou","sequence":"first","affiliation":[{"name":"Department of Gerontology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui 233004, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Ye","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui 233004, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenfang","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui 233004, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiling","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui 233004, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolin","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui 233004, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhua","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Neurology, Anhui Provincial Hospital Affiliated to Anhui Medical University, Hefei, Anhui 230001, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2019,3,14]]},"reference":[{"key":"key20200713120727_b1-etm-0-0-7397","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/mds.26510","article-title":"Nonmotor features of Parkinson's disease subtypes","volume":"31","author":"Marras","year":"2016","journal-title":"Mov Disord"},{"key":"key20200713120727_b2-etm-0-0-7397","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jns.2007.04.025","article-title":"dl-3n-butylphthalide prevents stroke via improvement of cerebral microvessels in RHRSP","volume":"260","author":"Liu","year":"2007","journal-title":"J Neurol Sci"},{"key":"key20200713120727_b3-etm-0-0-7397","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.neuint.2017.03.017","article-title":"DL-3-n-butylphthalide induced neuroprotection, regenerative repair, functional recovery and psychological benefits following traumatic brain injury in mice","volume":"111","author":"Zhao","year":"2017","journal-title":"Neurochem Int"},{"key":"key20200713120727_b4-etm-0-0-7397","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jalz.2015.04.010","article-title":"The effects of DL-3-n-butylphthalide in patients with vascular cognitive impairment without dementia caused by subcortical ischemic small vessel disease: A multicentre, randomized, double-blind, placebo-controlled trial","volume":"12","author":"Jia","year":"2016","journal-title":"Alzheimers Dement"},{"key":"key20200713120727_b5-etm-0-0-7397","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.3760\/cma.j.issn.0366-6999.20123240","article-title":"Ninety-day administration of dl-3-n-butylphthalide for acute ischemic stroke: A randomized, double-blind trial","volume":"126","author":"Cui","year":"2013","journal-title":"Chin Med J (Engl)"},{"key":"key20200713120727_b6-etm-0-0-7397","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.neulet.2010.03.053","article-title":"dl-3-n-Butylphthalide prevents oxidative damage and reduces mitochondrial dysfunction in an MPP(+)-induced cellular model of Parkinson's disease","volume":"475","author":"Huang","year":"2010","journal-title":"Neurosc Lett"},{"key":"key20200713120727_b7-etm-0-0-7397","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1016\/j.neurobiolaging.2011.03.007","article-title":"Dl-3-n-butylphthalide, a natural antioxidant, protects dopamine neurons in rotenone models for Parkinson's disease","volume":"33","author":"Xiong","year":"2012","journal-title":"Neurobiol Aging"},{"key":"key20200713120727_b8-etm-0-0-7397","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson's disease: A clinico-pathological study of 100 cases","volume":"55","author":"Hughes","year":"1992","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key20200713120727_b9-etm-0-0-7397","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1002\/mds.25380","article-title":"A two-year randomized controlled trial of progressive resistance exercise for Parkinson's disease","volume":"28","author":"Corcos","year":"2013","journal-title":"Mov Disord"},{"key":"key20200713120727_b10-etm-0-0-7397","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S1353-8020(99)00051-6","article-title":"Parkinson's disease subtypes: Clinical classification and ventricular cerebrospinal fluid analysis","volume":"6","author":"Schiess","year":"2000","journal-title":"Parkinsonism Relat Disord"},{"key":"key20200713120727_b11-etm-0-0-7397","first-page":"338","article-title":"Revision of the physical activity readiness questionnaire (PAR-Q)","volume":"17","author":"Thomas","year":"1992","journal-title":"Can J Sport Sci"},{"key":"key20200713120727_b12-etm-0-0-7397","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S1474-4422(15)00186-6","article-title":"Insights from late-onset familial parkinsonism on the pathogenesis of idiopathic Parkinson's disease","volume":"14","author":"Volta","year":"2015","journal-title":"Lancet Neurol"},{"key":"key20200713120727_b13-etm-0-0-7397","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S1474-4422(15)00227-6","article-title":"Multitarget disease-modifying therapy in Parkinson's disease?","volume":"14","author":"Calabresi","year":"2015","journal-title":"Lancet Neurol"},{"key":"key20200713120727_b14-etm-0-0-7397","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/mds.20369","article-title":"FP-CIT and MIBG scintigraphy in early Parkinson's disease","volume":"20","author":"Spiegel","year":"2005","journal-title":"Mov Disord"},{"key":"key20200713120727_b15-etm-0-0-7397","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1353-8020(00)00047-X","article-title":"Diagnosis and differential diagnosis of Parkinson's disease and parkinsonism","volume":"7","author":"Ahlskog","year":"2000","journal-title":"Parkinsonism Relat Disord"},{"key":"key20200713120727_b16-etm-0-0-7397","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.3892\/mmr.2012.1104","article-title":"Different patterns of cardiac sympathetic denervation in tremor-type compared to akinetic-rigid-type Parkinson's disease: Molecular imaging with \u00b923I-MIBG","volume":"6","author":"Chiaravalloti","year":"2012","journal-title":"Mol Med Rep"},{"key":"key20200713120727_b17-etm-0-0-7397","first-page":"881","article-title":"Different patterns of nigrostriatal degeneration in tremor type versus the akinetic-rigid and mixed types of Parkinson's disease at the early stages: Molecular imaging with 123I-FP-CIT SPECT","volume":"28","author":"Schillaci","year":"2011","journal-title":"Int J Mol Med"},{"key":"key20200713120727_b18-etm-0-0-7397","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/mds.25020","article-title":"Is alpha-synuclein in the colon a biomarker for premotor Parkinson's disease? Evidence from 3 cases","volume":"27","author":"Shannon","year":"2012","journal-title":"Mov Disord"},{"key":"key20200713120727_b19-etm-0-0-7397","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1002\/mds.26048","article-title":"Norepinephrine deficiency in Parkinson's disease: The case for noradrenergic enhancement","volume":"29","author":"Espay","year":"2014","journal-title":"Mov Disord"},{"key":"key20200713120727_b20-etm-0-0-7397","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.lfs.2016.09.009","article-title":"dl-3-n-Butylphthalide attenuation of methamphetamine-induced neurotoxicity in SH-SY5Y neuroblastoma cells","volume":"165","author":"Zhao","year":"2016","journal-title":"Life Sci"},{"key":"key20200713120727_b21-etm-0-0-7397","doi-asserted-by":"crossref","first-page":"39444","DOI":"10.18632\/oncotarget.8548","article-title":"5d, a novel analogue of 3-n-butylphthalide, decreases NADPH oxidase activity through the positive regulation of CK2 after ischemia\/reperfusion injury","volume":"7","author":"Zhou","year":"2016","journal-title":"Oncotarget"},{"key":"key20200713120727_b22-etm-0-0-7397","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1590\/S0100-879X2012007500039","article-title":"Protection against neurotoxicity by an autophagic mechanism","volume":"45","author":"Liu","year":"2012","journal-title":"Braz J Med Biol Res"},{"key":"key20200713120727_b23-etm-0-0-7397","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/glia.20467","article-title":"Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration","volume":"55","author":"Qin","year":"2007","journal-title":"Glia"},{"key":"key20200713120727_b24-etm-0-0-7397","doi-asserted-by":"crossref","first-page":"306","DOI":"10.3389\/fnins.2015.00306","article-title":"Abnormal lipopolysaccharide binding protein as marker of gastrointestinal inflammation in Parkinson disease","volume":"9","author":"Pal","year":"2015","journal-title":"Front Neurosci"},{"key":"key20200713120727_b25-etm-0-0-7397","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.tem.2016.08.003","article-title":"Linking the microbiota, chronic disease, and the immune system","volume":"27","author":"Hand","year":"2016","journal-title":"Trends Endocrinol Metab"},{"key":"key20200713120727_b26-etm-0-0-7397","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","article-title":"Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease","volume":"167","author":"Sampson","year":"2016","journal-title":"Cell"},{"key":"key20200713120727_b27-etm-0-0-7397","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/mds.26421","article-title":"Neuropathology of \u03b1-synuclein propagation and braak hypothesis","volume":"31","author":"McCann","year":"2016","journal-title":"Mov Disord"},{"key":"key20200713120727_b28-etm-0-0-7397","doi-asserted-by":"crossref","first-page":"98242","DOI":"10.18632\/oncotarget.21529","article-title":"Dl-3n-butylphthalide reduces epileptiform activity through GluA2-lacking calcium-permeable AMPARs in epilepsy models","volume":"8","author":"Yang","year":"2017","journal-title":"Oncotarget"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"deposited":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T19:52:18Z","timestamp":1721073138000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/etm.2019.7397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,14]]},"references-count":28,"URL":"https:\/\/doi.org\/10.3892\/etm.2019.7397","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,14]]}}}